Argentina
Industry
Argentina is to introduce new rules governing clinical trials from March, lending weight to BMI's view that the country's regulatory environment is on an upward trajectory. The rules...
2008-02-18Companies
Following positive steps by Argentina to improve its regulatory environment, BMI has upgraded the country's Business Environment Rating (BER) for the Approvals Process subcategory...
2007-12-14Industry
Two recent decisions by Argentina's medicines regulator ANMAT that mirror directives issued by the US FDA have served to demonstrate that it is watching the US regulator closely when...
2007-11-14Companies
In what is being seen as a sign that Argentine drugmakers are increasingly looking to international expansion to reduce exposure to their erratic home market, Laboratorios Bagó has...
2007-10-25Companies
The Argentine pharmaceutical market was valued at US$2.4bn in 2006 and continues to expand steadily. Sales are expected to reach US$3.0bn in 2011. While the market has recovered from...
2007-06-06Companies
US drugmaker Eli Lilly and local player HLB Pharma have announced investments in research and production in Argentina, in what is still, in BMI's view, one of the most difficult local...
2007-02-09Companies
Argentine pharmaceutical group Laboratorios Richmond is planning to invest US$10mn in equipment and upgrades at a recently purchased facility to produce oncology and generic, bio-equivalent...
2007-01-09Companies
The World Health Organisation (WHO) has warned that Latin America remains one of the regions worst affected by illegal medicines such as counterfeits. IMPACT - a new working group...
2006-11-20
